Toronto, Canada

Joseph A Araujo

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Joseph A Araujo: Innovator in Neurological Treatments

Introduction

Joseph A Araujo is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of neuroscience through his innovative patents. With a total of 4 patents, Araujo's work focuses on developing novel compounds and systems aimed at improving cognitive functions and treating neurological disorders.

Latest Patents

Araujo's latest patents include groundbreaking inventions such as compounds for the treatment of seizures and other central nervous system disorders. This application relates to novel compounds that lead to the metabolic production of ketones, which are bonded to a ketone-potentiated anti-epileptic drug. These compounds and their compositions are particularly useful for treating epilepsy and other CNS diseases. Another significant patent is a system and method for cognitive enrichment of an animal. This invention involves a display device that presents stimuli to an animal, an input device for accepting responses, and a reward dispenser that provides rewards based on the animal's interactions.

Career Highlights

Throughout his career, Araujo has worked with various companies, including Cancog Technologies, Inc. and Ketogen Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in neurological treatments.

Collaborations

Araujo has collaborated with notable individuals in his field, including John S Andrews and Subhash Annedi. These partnerships have further enhanced his research and development efforts.

Conclusion

Joseph A Araujo stands out as an influential inventor in the realm of neurological treatments. His innovative patents and collaborative efforts continue to pave the way for advancements in the treatment of CNS disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…